ProBioGen

ProBioGen gains operational control of Berlin’s advanced therapy manufacturing hub

German biotechnology company ProBioGen has been selected to design, construct, and operate the GMP manufacturing facility at Berlin’s new Centre for Gene and Cell Therapies, establishing a critical infrastructure node for translating advanced therapeutic research into clinical applications across Europe.

EuropaBiosite

Europa Biosite secures exclusive UK and Ireland distribution partnership for premium antibodies

Bioscience will serve as the exclusive UK and Ireland distributor for Bio X Cell’s premium monoclonal antibody portfolio. The strategic partnership aims to enhance researcher access to high-quality functional antibodies across academic and biotech institutions throughout both regions.

Scherm­afbeelding 2025 09 26 om 16.30.34

Atelerix strengthens board with biotech veterans to accelerate global expansion

Biotech company, Atelerix, specialising in non-cryogenic cell preservation technology appoints industry leaders Sunil Shah and Dr Catherine Elton to drive commercial scale-up and international market penetration across life sciences sectors.

AdobeStock 1686456001

BioMed X partners with Novo Nordisk to tackle oral peptide delivery challenges

German research institute BioMed X has announced a collaboration with Danish pharmaceutical giant Novo Nordisk to develop innovative oral formulation technologies for peptide drugs, including GLP-1 receptor agonists. The partnership aims to overcome critical barriers in oral peptide bioavailability through novel retention mechanisms in the lower small intestine. BioMed X, the independent biomedical research institute […]

beckman Biomeki7

Beckman Coulter collaborates with HSE to integrate automated nucleic acid quantification

Beckman Coulter Life Sciences has formed a strategic partnership with Swiss engineering firm HSE•AG to integrate UV photometry and fluorometry directly into liquid handling workflows. The collaboration embeds HSE’s eviDense and eviFluor instruments onto Biomek automated workstations, enabling real-time nucleic acid analysis without manual intervention. Beckman Coulter Life Sciences, the Danaher subsidiary and laboratory automation […]

PHC LiCellMo

PHC Corporation’s biomedical division honoured with R&D 100 Award for live cell analyser

PHC Corporation’s biomedical division has received a 2025 R&D 100 Award for LiCellMo, a live cell metabolic pathway analyser that provides continuous real-time monitoring of glucose and lactate levels in cell cultures. The device addresses critical needs in cell and gene therapy research by enabling non-invasive assessment of cellular metabolic states.

TestaAnalytical

TESTA Analytical partners with Mazet & Co to expand market reach

German flowmeter specialist TESTA Analytical has formed a strategic partnership with French distributor Mazet & Co to expand market reach across French-speaking regions in Europe and North Africa. The collaboration aims to deliver advanced flow measurement solutions for liquid chromatography applications, addressing growing demand for high-precision monitoring systems in analytical and preparative laboratories.

diaago Collaborative Laboratory Robot

diaago teams up with Peak Analysis & Automation to expand laboratory automation access

diaago has announced a strategic partnership with Peak Analysis & Automation (PAA) to enhance laboratory automation capabilities. The collaboration combines PAA’s decades of robotics expertise with diaago’s distribution network, offering research laboratories flexible automation solutions including the KX-2 Collaborative Robot for streamlined workflows and improved throughput.

Eli Lilly tunelab

Eli Lilly opens AI drug discovery vault to biotech partners through billion-dollar TuneLab platform

Eli Lilly launches TuneLab, an artificial intelligence platform providing biotechnology companies access to drug discovery models trained on over $1 billion worth of proprietary research data. The federated learning system enables smaller companies to utilise Lilly’s AI capabilities whilst preserving data privacy through third-party hosting.

Cyted Health

Cyted Health secures £44 million Series B funding to advance oesophageal cancer diagnostics

Cambridge-based molecular diagnostics company Cyted Health has completed a $44 million Series B financing round to accelerate commercial expansion of its minimally invasive oesophageal cancer detection platform across the United States, following successful deployment of over 35,000 tests within the NHS.